Superior survival in treatment of primary nonmetastatic pediatric osteosarcoma of the extremity

Annals of Surgical Oncology

Volumn 10, Issue 5, 2003, Pages 498-507

  Wilkins, Ross M ^a   Cullen, John W ^a   Odom, Lorrie ^b   Jamroz, Brandt A ^a   Cullen, Patsy McGuire ^a   Fink, Kyle ^a   Peck, Sanford D ^a   Stevens, Sydney L ^a   Kelly, Cynthia M ^a   Camozzi, Anne B ^a  

^a PRESBYTERIAN ST LUKE S MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

Cisplatin; Doxorubicin; Infusions; Intra arterial; Osteosarcoma; Tumor vascularity

Indexed keywords

CISPLATIN; DOXORUBICIN; ANTINEOPLASTIC AGENT;

ACCURACY; ADOLESCENT; ADULT; ARTERIOGRAPHY; ARTICLE; CANCER RELAPSE; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; KAPLAN MEIER METHOD; LIMB; MALE; MEDICAL DOCUMENTATION; OSTEOSARCOMA; SCHOOL CHILD; SURGICAL TECHNIQUE; TUMOR NECROSIS; BLOOD FLOW; BONE TUMOR; CANCER STAGING; CHILD; CLINICAL TRIAL; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MULTICENTER STUDY; NEOVASCULARIZATION (PATHOLOGY); PROGNOSIS; SURVIVAL; TUMOR RECURRENCE; VASCULARIZATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; CISPLATIN; DOXORUBICIN; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; OSTEOSARCOMA; PROGNOSIS; REGIONAL BLOOD FLOW; SURVIVAL ANALYSIS;

EID: 0041784839     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2003.03.061     Document Type: Article

References (35)

1. Bacci G, Ferrari S, Bertoni F, et al. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report. J Clin Oncol 2000;18:4016-27.
2. Brosjo O. Surgical procedure and local recurrence in 224 patients treated 1982-1997 according to two osteosarcoma chemotherapy protocols. The Scandinavian Sarcoma Group experience. Acta Orthop Scand Suppl 1999;285:58-61.
3. Ettinger LJ, Douglass HO, Higby DJ, et al. Adjuvant adriamycin and cis-diamminedichloroplatinum (cis-platinum) in primary osteosarcoma. Cancer 1981;47:248-54.
4. Ferrari S, Bacci G, Picci P, et al. Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Ann Oncol 1997;8:765-71.
5. Fuchs N, Bielack SS, Epler D, et al. Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 1998;9:893-9.
6. Honegger HP, Cserhati MD, Exner GU, von Hochstetter A, Groscurth P. Zurich experience with preoperative, high dose methotrexate-containing chemotherapy in patients with extremity osteosarcomas (OSA). Ann Oncol 1991;2:489-94.
7. Marcove RC, Mike V, Hajek JV, Levin AG, Hutter RV. Osteogenic sarcoma under the age of twenty-one. A review of one hundred and forty-five operative cases. J Bone Joint Surg Am 1970;52:411-23.
8. Mercuri M, Capanna R, Manfrini M, et al. The management of malignant bone tumors in children and adolescents. Clin Orthop 1991;264:156-68.
9. Pathak AB, Advani SH, Lyer RS, et al. Adjuvant chemotherapy for osteogenic sarcoma of the extremity with sequential adriamycin and cisplatin. J Surg Oncol 1993;52:181-4.
10. Philip T, Iliescu C, Demaille MC, et al. High-dose methotrexate and HELP [Holoxan (ifosfamide), eldesine (vindesine), platinum]-doxorubicin in non-metastatic osteosarcoma of the extremity: a French multicentre pilot study. Federation Nationale des Centres de Lutte contre le Cancer and Societe Francaise d'Oncologie Pediatrique. Ann Oncol 1999;10:1065-71.
11. Provisor AJ, Ettinger LJ, Nachman JB, et al. Treatment of non-metastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 1997;15:76-84.
12. Cara JA, Canadell J. Limb salvage for malignant bone tumors in young children. J Pediatr Orthop 1994;14:112-8.
13. Souhami RL, Craft AW, Van der Eijken JW, et al. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet 1997;350: 911-7.
14. Uchida A, Myoui A, Araki N, Yoshikawa H, Shinto Y, Ueda T. Neoadjuvant chemotherapy for pediatric osteosarcoma patients. Cancer 1997;79:411-5.
15. Stewart DJ, Benjamin RS, Zimerman S, et al. Clinical pharmacology of intraarterial cis-diamminedichloroplatinum (II). Cancer Res 1983;43:917-20.
16. Carrasco CH, Chamsangavej C, Raymond AK, et al. Osteosarcoma: angiographic assessment of response to preoperative chemotherapy. Radiology 1989;170:839-42.
17. Huvos AG, Rosen G, Marcove RC. Primary osteogenic sarcoma: pathologic aspects in 10 patients after treatment with chemotherapy, en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med 1977;101:14-8.
18. Enneking WF. A system for the functional evaluation of the surgical management of musculoskeletal tumors. In: Enneking WF, ed. Limb Salvage in Musculoskeletal Oncology. New York: Churchill Livingstone, 1987:5-16.
19. Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard D. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop 1993;286:241-6.
20. Wilkins RM, Soubeiran A. The Phenix expandable prosthesis: early American experience. Clin Orthop 2001;382:51-8.
21. Bacci G, Ferrari S, Longhi A, et al. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol. J Chemother 2001;13:93-9.
22. Bacci G, Ferrari S, Mercuri M, et al. Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy. Acta Orthop Scand 1998;69:230-6.
23. Jaffe N, Knapp J, Chuang V, et al. Osteosarcoma: intra-arterial treatment of the primary tumor with cis-diamminedichloroplatinum II (CDP); angiographie, pathologic, and pharmacologic studies. Cancer 1983;51:402-7.
24. Jaffe N, Raymond K, Ayala A, et al. Effect of cumulative courses of intraarterial cis-diamminedichloroplatin-II on the primary tumor in osteosarcoma. Cancer 1989;63:63-7.
25. Bacci G, Ferrari S, Tienghi A, et al. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity. Eur J Surg Oncol 2001;27:98-104.
26. Ferrari S, Mercuri M, Picci P, et al. Nonmetastatic osteosarcoma of the extremity: results of a neoadjuvant chemotherapy protocol (IOR/OS-3) with high-dose methotrexate, intra-arterial or intravenous cisplatin, doxombicin, and salvage chemotherapy based on histologic tumor response. Tumori 1999;85:458-64.
27. Rha SY, Chung HC, Gong SJ, et al. Combined preoperative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma. Oncol Rep 1999;6: 631-7.
28. Winkler K, Bielack S, Delling G, et al. Effect of intra-arterial versus intravenous cisplatin in addition to systemic doxombicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (Study COSS-86). Cancer 1990;66:1703-10.
29. Abudu A, Sferopoulos NK, Tillman RM, Carter SR, Grimer RJ. The surgical treatment and outcome of pathological fractures in localised osteosarcoma. J Bone Joint Surg Br 1996;78:694-8.
30. Scully SP, Temple HT, O'Keefe RJ, Mankin HJ, Gebhardt M. The surgical treatment of patients with osteosarcoma who sustain a pathologic fracture. Clin Orthop 1996;324:227-32.
31. Bezwada HP, Granick MS, Long CD, et al. Soft-tissue complications of intra-arterial chemotherapy for extremity sarcomas. Ann Plast Surg 1998;40:382-7.
32. Cheon JE, Kim IO, Kim WS, et al. Abdominal-wall myositis secondary to intra-arterial chemotherapy for femoral osteosarcoma. Pediatr Radiol 1999;29:546-8.
33. Tsuchiya H, Morinaga T, Taki J, et al. Effect of myocutaneous inflammatory changes caused by intra-arterial chemotherapy on the outcome of patients who undergo limb-saving surgery. Cancer 2001;91:2447-53.
34. Benjamin RS, Chawla SP, Carrasco CH, et al. Preoperative chemotherapy for osteosarcoma with intravenous adriamycin and intra-arterial cis-platinum. Ann Oncol 1992;3:3-6.
35. Quintana J, Beresi V, DelPozo H, et al. Intra-arterial cisplatin given prior to surgery in osteosarcoma: grade of necrosis and size of tumor as major prognostic factors. Am J Pediatr Hematol Oncol 1991;13:269-73.